Ambry Genetics, Cell Line Genetics Ink Sales Pact | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Cell Line Genetics will sell Ambry Genetics' StemArray aCGH product and related services under an agreement announced today.

Madison, Wis.-based CLG will sell the StemArray products and services to its current customers and other companies and research institutions. CLG will offer the StemArray services through its own labs.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.